A1324 - 3-fucosyllactose as a nutritive substance in infant formula products

To permit the voluntary addition of 3-fucosyllactose, a human-identical milk oligosaccharide, in infant formula products. The 3-fucosyllactose is produced using genetically modified Escherichia coli K-12. 

Approval

• A1324 Approval report (717KB)
• A1324 Supporting document (at Approval) (600KB)

Call for submissions

• A1324 Call for submissions (524KB)
• A1324 Supporting document (594KB)
• A1324 Application (3.89MB)

The call for submissions was completed on 11 June 2025. The submissions from this public consultation are available on the A1324 activity page of the FSANZ Consultation Hub.

Administrative Assessment

• A1324 Administrative assessment report (134KB)
• A1324 Executive summary (167KB)